These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 25612289

  • 21. Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis.
    Rodríguez E, Elia C, Solà E, Barreto R, Graupera I, Andrealli A, Pereira G, Poca M, Sánchez J, Guevara M, Soriano G, Alessandria C, Fernández J, Arroyo V, Ginès P.
    J Hepatol; 2014 May; 60(5):955-61. PubMed ID: 24447876
    [Abstract] [Full Text] [Related]

  • 22. A study on clinical outcomes of combination of terlipressin and albumin in Hepatorenal Syndrome.
    Krishna R, Raj J, Dev D, Prasad SC, Reghu R, V SO.
    Scand J Gastroenterol; 2020 Jul; 55(7):860-864. PubMed ID: 32634332
    [Abstract] [Full Text] [Related]

  • 23. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials.
    Sagi SV, Mittal S, Kasturi KS, Sood GK.
    J Gastroenterol Hepatol; 2010 May; 25(5):880-5. PubMed ID: 20074149
    [Abstract] [Full Text] [Related]

  • 24. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics.
    Boyer TD, Sanyal AJ, Garcia-Tsao G, Blei A, Carl D, Bexon AS, Teuber P, Terlipressin Study Group.
    J Hepatol; 2011 Aug; 55(2):315-21. PubMed ID: 21167235
    [Abstract] [Full Text] [Related]

  • 25. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
    Sharma P, Kumar A, Shrama BC, Sarin SK.
    Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715
    [Abstract] [Full Text] [Related]

  • 26. Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes.
    Rodriguez E, Henrique Pereira G, Solà E, Elia C, Barreto R, Pose E, Colmenero J, Fernandez J, Navasa M, Arroyo V, Ginès P.
    Liver Transpl; 2015 Nov; 21(11):1347-54. PubMed ID: 26178066
    [Abstract] [Full Text] [Related]

  • 27. Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials.
    Fabrizi F, Dixit V, Messa P, Martin P.
    Int J Artif Organs; 2009 Mar; 32(3):133-40. PubMed ID: 19440988
    [Abstract] [Full Text] [Related]

  • 28. Hepatorenal syndrome.
    Angeli P, Morando F, Cavallin M, Piano S.
    Contrib Nephrol; 2011 Mar; 174():46-55. PubMed ID: 21921608
    [Abstract] [Full Text] [Related]

  • 29. Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.
    Piano S, Schmidt HH, Ariza X, Amoros A, Romano A, Hüsing-Kabar A, Solà E, Gerbes A, Bernardi M, Alessandria C, Scheiner B, Tonon M, Maschmeier M, Solè C, Trebicka J, Gustot T, Nevens F, Arroyo V, Gines P, Angeli P, EASL CLIF Consortium, European Foundation for the Study of Chronic Liver Failure (EF Clif).
    Clin Gastroenterol Hepatol; 2018 Nov; 16(11):1792-1800.e3. PubMed ID: 29391267
    [Abstract] [Full Text] [Related]

  • 30. Poor outcomes with treatment of hepatorenal syndrome type 1 with splanchnic vasoconstrictors and albumin: report of seven cases and review of the literature.
    Kalil JR, Cerqueira LA, Barbosa DS, Motta MP, Nery Mda S, Bittencourt PL.
    Arq Gastroenterol; 2009 Nov; 46(3):214-8. PubMed ID: 19918689
    [Abstract] [Full Text] [Related]

  • 31. Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome.
    Piano S, Gambino C, Vettore E, Calvino V, Tonon M, Boccagni P, Gringeri E, Germani G, Burra P, Cillo U, Angeli P.
    Hepatology; 2021 May; 73(5):1909-1919. PubMed ID: 32870499
    [Abstract] [Full Text] [Related]

  • 32. Hepatorenal syndrome and novel advances in its management.
    Fabrizi F, Aghemo A, Messa P.
    Kidney Blood Press Res; 2013 May; 37(6):588-601. PubMed ID: 24356549
    [Abstract] [Full Text] [Related]

  • 33. Terlipressin in hepatorenal syndrome: Evidence for present indications.
    Rajekar H, Chawla Y.
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
    [Abstract] [Full Text] [Related]

  • 34. Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study.
    Halimi C, Bonnard P, Bernard B, Mathurin P, Mofredj A, di Martino V, Demontis R, Henry-Biabaud E, Fievet P, Opolon P, Poynard T, Cadranel JF.
    Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):153-8. PubMed ID: 11981339
    [Abstract] [Full Text] [Related]

  • 35. Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation?
    Piano S, Morando F, Fasolato S, Cavallin M, Boscato N, Boccagni P, Zanus G, Cillo U, Gatta A, Angeli P.
    J Hepatol; 2011 Aug; 55(2):491-6. PubMed ID: 21334405
    [Abstract] [Full Text] [Related]

  • 36. Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice.
    Angeli P, Gines P.
    J Hepatol; 2012 Nov; 57(5):1135-40. PubMed ID: 22749942
    [Abstract] [Full Text] [Related]

  • 37. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.
    Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, Blei A, Gülberg V, Sigal S, Teuber P, Terlipressin Study Group.
    Gastroenterology; 2008 May; 134(5):1360-8. PubMed ID: 18471513
    [Abstract] [Full Text] [Related]

  • 38. Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study.
    Ghosh S, Choudhary NS, Sharma AK, Singh B, Kumar P, Agarwal R, Sharma N, Bhalla A, Chawla YK, Singh V.
    Liver Int; 2013 Sep; 33(8):1187-93. PubMed ID: 23601499
    [Abstract] [Full Text] [Related]

  • 39. The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study.
    Fimiani B, Guardia DD, Puoti C, D'Adamo G, Cioffi O, Pagano A, Tagliamonte MR, Izzi A.
    Eur J Intern Med; 2011 Dec; 22(6):587-90. PubMed ID: 22075285
    [Abstract] [Full Text] [Related]

  • 40. [A comparative study of high-or low-dose terlipressin therapy in patients with cirrhosis and type 1 hepatorenal syndrome].
    Wan S, Wan X, Zhu Q, Peng J.
    Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):349-53. PubMed ID: 25180869
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.